A history of success in genomics, technological innovation & business
Founder & former CEO of Celmatix, a leader in genomics and pharma target generation of women’s health. Laura is a graduate of the Weill Cornell Graduate School of Medical Sciences and Memorial Sloan Kettering Cancer Center doctoral program.
Founding partner at venture fund SOSVs life sciences practice, co-founder of Coder Dojo and currently runs RebelBio in Europe. Bill is an entrepreneur, venture investor, diplomat, author, and speaker with a distinguished record in the areas of business, development and community activism.
Head of Corporate Development of ACC Group, focused on the engineering sector across MENA. Sami is an active investor and previously a board member of Synthace Ltd.
Managing Director of JLC Precision Health Strategies, with a track record of developing innovative data-driven strategies and solutions at the intersection of healthcare IT and services, patient-specific data and machine learning, precision medicine. Founder of N of 1, acquired by Qiagen in 2019.